Skip to main content
Log in

Drug-Induced Nail Abnormalities

  • Practical Dermatology
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

This article reviews the different nail symptoms produced by drugs. Drug-induced nail abnormalities may result from toxicity to the matrix, the nail bed or the periungual tissues. The most common symptoms include Beau’s lines/onychomadesis, melanonychia, onycholysis, and periungual pyogenic granulomas. Nail changes usually affect several nails and in most cases are asymptomatic. Drugs that most frequently produce nail abnormalities include retinoids, indinavir, and cancer chemotherapeutic agents. In this article, we also include nail adverse effects as a result of radiotherapy since they are commonly observed in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Tosti A., Baran R., Dawber R.P.R. The nail in systemic diseases and drug-induced changes. In: Baran R., Dawber R.P.R., de Berker D.A.R., et al., editors. Baran and Dawber’s diseases of the nails and their management. 2nd ed. Oxford: Blackwell Science, 2001: 223–329

    Chapter  Google Scholar 

  2. Piraccini B.M., Tosti A. Drug-induced nail disorders: incidence, management and prognosis. Drug Saf 1999 Sep; 21 (3): 187–201

    Article  PubMed  CAS  Google Scholar 

  3. Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs or ingestans. J Am Acad Dermatol 1984 Feb; 10 (2): 250–258

    Article  PubMed  Google Scholar 

  4. Daniel III C.R., Scher R.K. Nail changes secondary to systemic drugs and ingestans. In: Sher R.K., Daniel III C.R. Nails: therapy, diagnosis, surgery. Philadelphia (PA): WB Saunders Company, 1997: 251–275

    Google Scholar 

  5. Baran R. Retinoids and the nail. J Dermatol Treat 1990; 1: 151–154

    Article  Google Scholar 

  6. Baran R., Kechijian P. Longitudinal melanonychia: diagnosis and management. J Am Acad Dermatol 1989 Dec; 21 (6): 1165–1175

    Article  PubMed  CAS  Google Scholar 

  7. Vanhooteghem O., Richert B., Vindevoghel A., et al. Subungual abscess: an ungual side-effect related to docetaxel therapy. Br J Dermatol 2000 Aug; 43 (2): 445–473

    Google Scholar 

  8. Hussain S., Anderson D.N., Salvatti M.E., et al. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer 2000 May; 88 (10): 2367–2371

    Article  PubMed  CAS  Google Scholar 

  9. Varotti C., Ghetti E., Piraccini B.M., et al. Subungual hematoma in a patient treated with an oral anticoagulant (warfarin sodium). Eur J Dermatol 1997; 7 (5): 395–396

    Google Scholar 

  10. Baran R. Etretinate and the nails (study of 130 cases): possible mechanisms of some side effects. Clin Exp Dermatol 1986; 11: 148–152

    Article  PubMed  CAS  Google Scholar 

  11. Bouscarat F., Bouchard C., Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients with indinavir. N Engl J Med 1998 Jun; 338 (24): 1776–1777

    Article  PubMed  CAS  Google Scholar 

  12. Calista D., Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000 Jun; 10 (4): 292–296

    PubMed  CAS  Google Scholar 

  13. Tosti A., Piraccini B.M., D’Antuono A., et al. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999 May; 140 (5): 1165–1168

    Article  PubMed  CAS  Google Scholar 

  14. Stringer M.D., Bentley P.G. Peripheral gangrene associated with ß-blockade. Br J Surg 1986; 73: 1008–1011

    Article  PubMed  CAS  Google Scholar 

  15. Behrens S., Reuther T., Von Kobyletzki G., et al. Bleomycin induzierte PSS-artige pseudokeerodermie. Hautarzt 1998; 49: 725–729

    Article  PubMed  CAS  Google Scholar 

  16. Wolf R., Tur E., Brenner S. Corticosteroid-induced “disappearing digit”. J Am Acad Dermatol 1990 Oct; 23 (4 Pt 1): 755–756

    Article  PubMed  CAS  Google Scholar 

  17. Holmes L.B., Harvey E.A., Brown K.S., et al. Anti-convulsant teratogenesis I: a study design for newborn infants. Teratology 1994; 49: 202–207

    Article  PubMed  CAS  Google Scholar 

  18. Pichini S., Altieri I., Zuccaro P., et al. Drug monitoring in non conventional biological fluids and matrices. Clin Pharmacokinet 1996 May–Jun; 30 (3): 221–228

    Article  Google Scholar 

  19. Lemos N.P., Anderson R.A., Robertson J.R. Nail analysis for drugs of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999 Mar; 23 (3): 147–152

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piraccini, B.M., Iorizzo, M. & Tosti, A. Drug-Induced Nail Abnormalities. Am J Clin Dermatol 4, 31–37 (2003). https://doi.org/10.2165/00128071-200304010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200304010-00004

Keywords

Navigation